We first noticed that several online websites showed that ARHGAP39 was abnormally highly expressed in hepatocellular carcinoma tissues, which was the same as the analysis conclusions of the TCGA and ICGC databases. Here, ARHGAP39 is linked to hepatocellular carcinoma.